Deutsche Bank’s AstraZeneca AZN Stock Holding History

Deutsche Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,046	Closed	-$284K	–	5128
2014 Q4	$284K	Buy	4,046 +1,109	+38%	+$79.4K	﹤0.01%	4093
2014 Q3	$209K	Buy	+2,937	New	+$215K	﹤0.01%	4040

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank's AZN Position: Q2 2026 in Review

Deutsche Bank increased its AstraZeneca (AZN) stake by 4.2% in Q2 2026, buying an estimated $96.1M and bringing the position to 12,640,672 shares worth $2.4B. The position accounts for 0.7% of the portfolio, ranked #21.

Deutsche Bank first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Deutsche Bank held 12,640,672 shares of AstraZeneca worth $2.4B as of Q2 2026.
Deutsche Bank bought 510,948 AstraZeneca shares in Q2 2026, an estimated $96.1M.
AstraZeneca made up 0.7% of Deutsche Bank's portfolio in Q2 2026, its #21 holding.
Deutsche Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.